The Motley Fool

Key Data Points

Primary metrics and data points about Celgene.
Current Price: $114.35
Prev Close: $114.91
Open: $115.30
Bid: $114.24
Ask: $114.32
Day's Range: $114.10 - $116.49
52wk Range: $82.90 - $129.06
Volume: 2,215,871
Avg Vol 3,884,600
Market Cap: $91B
P/E (ttm): 39.35
EPS (ttm): $2.92
Div & Yield: $0.00 (0.0%)

News and Headlines

Latest news about Celgene from Fool.com.

Business Summary

Industry, sector and description for Celgene.

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

CELG vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Celgene.
CAPS Rating 5 out of 5
 
1984 Outperform
74 Underperform
CAPS All Stars
 
511 Outperform
12 Underperform

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Robert J. Hugin, CEO

95% Approve

Based on 51 Ratings

More Details for CelgeneJobs

Powered by

More Details about Celgene

Primary metrics and data points about Celgene.